文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血相关神经功能结局与神经介入放射学现场可及性的关联

Association Between Neurological Outcomes Related to Aneurysmal Subarachnoid Hemorrhage and Onsite Access to Neurointerventional Radiology.
PubMed 文献 · World Neurosurg · 2018-02-02

该序贯时段研究比较了神经介入放射学(NIR)启用前(2010年1月至2012年6月,47例)与启用后(2013年1月至2015年6月,81例)连续收治的动脉瘤性蛛网膜下腔出血(aSAH)患者。主要终点为发病6个月时改良Rankin量表≥3分的不良神经功能结局发生率,前NIR期为38%(18/47) vs 后NIR期为31%(25/81),P=0.39,后NIR期校正比值比为0.8(95%CI 0.3-2.1;P=0.66),无独立影响。后NIR期症状性血管痉挛(SV)检出率更高(41% vs 21%,P=0.02),血管内操作更多、住院时间更长,但神经功能结局无显著改善。

要点

  • 后NIR期不良神经功能结局(mRS≥3)为31%(25/81) vs 前NIR期38%(18/47),P=0.39,无显著差异。
  • 后NIR期SV发生率为41%(33/81) vs 前NIR期21%(10/47),P=0.02,后NIR期和更高Fisher分级为SV独立预测因素。
  • 合并SV患者在后NIR期ICU住院时间更长,但两组神经功能结局相似。

核心结论

  • 在aSAH患者中,后NIR期与更频繁的SV检出、更多血管内操作、更长住院时间相关,但无论总体还是SV亚组,神经功能结局均无显著改善。

研究设计与样本

  • 序贯时段研究,在学术三级转诊ICU连续纳入前NIR期(2010年1月至2012年6月)47例aSAH患者,与后NIR期(2013年1月至2015年6月)81例aSAH患者进行比较。
  • 研究注册于澳大利亚新西兰临床试验注册中心,注册号ACTRN12616000201471。

主要发现

  • 主要终点(发病6个月时改良Rankin量表≥3分的不良神经功能结局)见于前NIR期18/47例(38%) vs 后NIR期25/81例(31%),P=0.39。
  • 后NIR期对神经功能结局无独立影响,校正比值比=0.8(95%CI 0.3-2.1;P=0.66)。
  • 发生SV的患者中,前NIR期为10/47例(21%) vs 后NIR期为33/81例(41%),P=0.02。
  • 后NIR期和更高Fisher分级是SV的独立预测因素。
  • 合并SV的患者两组结局相似,但后NIR期较前NIR期ICU住院时间更长。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: An onsite access to neurointerventional radiology (NIR) may be useful for managing patients with aneurysmal subarachnoid hemorrhage (aSAH) after the aneurysm-securing procedure. We aimed to assess the association between neurological outcomes related to aSAH and onsite access to NIR service. METHODS: This was a sequential period study of 47 patients with aSAH admitted consecutively during the pre-NIR period (January 2010 to June 2012) compared with 81 patients with aSAH admitted consecutively during the post-NIR period (January 2013 to June 2015) at an academic tertiary referral intensive care unit (ICU). The primary end point was the incidence of poor neurological outcome, defined as modified Rankin scale of ≥3 at 6 months from ictus. Secondary outcomes included incidence of symptomatic vasospasm (SV) and length of stay in ICU/hospital. RESULTS: The primary end point was observed in 18 of 47 (38%) patients during the pre-NIR period versus 25 of 81 (31%) patients during the post-NIR period (P = 0.39). The post-NIR period did not have an independent impact on neurological outcomes (adjusted odds ratio = 0.8, 95% confidence interval 0.3-2.1; P = 0.66). Of the patients who developed SV, 10 of 47 (21%) were during the pre-NIR period versus 33 of 81 (41%) during the post-NIR period (P = 0.02). The post-NIR period and higher Fisher grade were independent predictors of SV. Patients with SV had similar outcomes, but with longer stay in ICU during the post-NIR period compared with the pre-NIR period. CONCLUSIONS: Among patients with aSAH, the post-NIR period was associated with more frequent detection of SV, more endovascular procedures, longer hospital stay, but with no appreciable improvement in neurological outcomes either overall or in the subset of patients with SV. STUDY REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12616000201471.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Mogollon JP, Smoll NR, Panwar R, et al. Association Between Neurological Outcomes Related to Aneurysmal Subarachnoid Hemorrhage and Onsite Access to Neurointerventional Radiology. World Neurosurg. 2018. PMID: 29410100. doi:10.1016/j.wneu.2018.01.121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。